Title : Selective COX-2 inhibitors: a health economic perspective.

Pub. Date : 2003

PMID : 12705064






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Because of their better gastrointestinal risk profile, the newly developed selective COX-2 inhibitors celecoxib and rofecoxib are discussed as cost-effective alternatives to common NSAIDs. rofecoxib mitochondrially encoded cytochrome c oxidase II Homo sapiens